Table V.
Univariate analysis of factors according to the occurrence of complications in patients aged ≥80 years.
| Factor | Complication group (≥80 years; n=12) | No complication group (≥80 years; n=32) | P-value |
|---|---|---|---|
| Age (years) | 83.5±3.1 | 83.2±3.0 | 0.83 |
| Gender (male/female) | 4/8 | 11/21 | 0.94 |
| Diabetes (n) | 3 (25%) | 6 (19%) | 0.64 |
| Hypertension (n) | 5 (42%) | 15 (47%) | 0.16 |
| Alcohol abuse (n) | 2 (17%) | 6 (19%) | 0.87 |
| Hepatitis C (n) | 5 (42%) | 15 (47%) | 0.16 |
| NBNC (n) | 7 (58%) | 16 | 0.62 |
| Platelet count (104/µl) | 17.5±5.2 | 19.3±9.0 | 0.74 |
| Prothrombin activity (%) | 91.1±14.1 | 95.4±11.2 | 0.52 |
| AST (IU/l) | 42.9±21.5 | 45.1±24.1 | 0.92 |
| ALT (IU/l) | 31.8±20.9 | 34.4±27.4 | 0.92 |
| ALP (IU/l) | 437±248 | 36±212 | 0.47 |
| γ-GTP (IU/l) | 139±129 | 75±72 | 0.22 |
| Albumin (g/dl) | 3.5±0.4 | 3.8±0.4 | 0.02 |
| Total bilirubin (mg/dl) | 0.7±0.2 | 0.6±0.2 | 0.48 |
| CRP (mg/dl) | 2.5±3.7 | 0.2±0.2 | 0.18 |
| Cholinesterase (IU/l) | 208±60 | 217±70 | 0.91 |
| ICGR-15 (%) | 18.2±5.4 | 14.0±7.8 | 0.01 |
| AFP (ng/ml) | 3,235±5,999 | 296±1171 | 0.36 |
| DCP (mAU/ml) | 5,263±9,023 | 5,567±16,357 | 0.32 |
| Maximum tumor size (cm) | 8.4±13.1 | 6.4±7.5 | 0.77 |
| Tumor number (single/multiple) | 6/6 | 22/10 | 0.24 |
| Operative method (anatomic/limited) | 4/8 | 15/17 | 0.41 |
| Operation time (min) | 396±125 | 299±108 | 0.01 |
| Intraoperative bleeding (ml) | 1,625±904 | 862±841 | <0.01 |
| Allogeneic transfusion (n) | 5 (42%) | 6 (19%) | 0.10 |
AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; γ-GTP, gamma-glutamyl transpeptidase; CRP, C-reactive protein; ICGR-15, indocyanine green retention rate at 15 min; AFP, α-fetoprotein; DCP, des-gamma-carboxy prothrombin; NBNC, NBNC, negative for hepatitis B and C. Data are expressed as the mean ±standard deviation.